NCT05300048 2025-10-06Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA MutationsFaeth TherapeuticsPhase 1 Completed34 enrolled
NCT04047862 2025-08-22Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid TumorsBeiGenePhase 1 Completed446 enrolled 49 charts